This fellowship is offered to young postdoctoral neuroscientists to facilitate their conduct of and training in basic, clinical or applied research related to MS in European laboratories or clinics. The goal is to maximize exchange of information and help grow the pool of well-trained scientists focused on MS.
ECTRIMS will support up to three fellowships annually, each with duration of 1 or 2 years, with an annual stipend of €50,000. Fellows are expected to identify a European research training environment and mentor prior to application and to devote full-time to research and training during their fellowship period (up to 10% time and effort can be spent on teaching and/or clinical care).
This fellowship is offered to neurologists and other physicians to provide the opportunity to learn the latest techniques in patient management and care and to help foster their careers as MS physicians. It is available for 3, 6 or 12 months and must be performed under the direction of a senior clinical mentor at a European MS clinic and/or MS research center. Fellows may come from any location but priority will be given to candidates from developing countries.
ECTRIMS will award up to three fellowships annually, with a stipend of up to €50,000. The programme is intended to be a full-time MS clinical care training experience. This can include 'hands on' clinical care under the guidance of the mentor, correlated course work in the training institutions, and may also include time involved in clinical research under the guidance of the mentor.
This fellowship is offered to qualified/licensed European nurses to provide the opportunity for them to obtain additional expertise through practical nursing experience and training in a mentored MS environment in Europe. The aim of the programme is to enhance care and support of individuals with MS by fostering improved clinical care and education and by helping to promote best practices in nursing care throughout Europe.
ECTRIMS will support up to three fellowships each year, each with duration of 6 months to 1 year, with a stipend of up to €50,000. Training must be under the direction and mentorship of a senior MS nurse, in association with a senior MS clinician where appropriate, at a European clinical site with significant expertise in MS.
ECTRIMS and the European MAGNIMS (Magnetic Resonance in MS) network jointly support a postdoctoral fellowship to foster the development of young researchers in magnetic resonance studies in MS. The goal of this programme is to achieve transfer and broadening of knowledge regarding the application of magnetic resonance to MS research and to promote the researcher’s integration into the international scientific community.
ECTRIMS will support two fellowships annually, each with duration of 1 year, with an annual stipend of up to €50,000.
2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment
A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers, MD, FAHA, Chair, Colin P. Derdeyn, MD, FAHA, Vice Chair, José Biller, MD, FAHA, Christopher S. Coffey, PhD, Brian L. Hoh, MD, FAHA, Edward C. Jauch, MD, MS, FAHA, Karen C. Johnston, MD, MSc, S. Claiborne Johnston, MD, PhD, FAHA, Alexander A. Khalessi, MD, MS, FAHA, Chelsea S. Kidwell, MD, FAHA, James F. Meschia, MD, FAHA, Bruce Ovbiagele, MD, MSc, MAS, FAHA and Dileep R. Yavagal, MD, MBBS; on behalf of the American Heart Association Stroke Council
Purpose—The aim of this guideline is to provide a focused update of the current recommendations for the endovascular treatment of acute ischemic stroke. Where there is overlap, the recommendations made here supersede those of previous guidelines.
Methods—This focused update analyzes results from 8 randomized clinical trials of endovascular treatment and other relevant data published since 2013. It is not intended to be a complete literature review from the date of the previous guideline publication but rather to include pivotal new evidence that justifies changes in current recommendations. Members of the writing committee were appointed by the American Heart Association/American Stroke Association Stroke Council’s Scientific Statement Oversight Committee and the American Heart Association/American Stroke Association Manuscript Oversight Committee (MOC). Strict adherence to the American Heart Association conflict of interest policy was maintained throughout the consensus process. Recommendations follow the American Heart Association/American Stroke Association methods of classifying the level of certainty of the treatment effect and the class of evidence. Prerelease review of the draft guideline was performed by 6 expert peer reviewers and by the members of the Stroke Council Scientific Statement Oversight Committee and Stroke Council Leadership Committee.
Results—Evidence-based guidelines are presented for the selection of patients with acute ischemic stroke for endovascular treatment, the endovascular procedure and for systems of care to facilitate endovascular treatment.
Conclusions—Certain endovascular procedures have been demonstrated to provide clinical benefit in selected patients with acute ischemic stroke. Systems of care should be organized to facilitate the delivery of this care.
It is our pleasure to introduce the 9th International Congress on Vascular Dementia – ICVD 2015, which will be held in Ljubljana, Slovenia, 16-18 October, 2015.
ICVD 2015 will be a showcase for the discussion of new developments in the area of dementia with special attention to cerebrovascular diseases affecting cognition and behavior. The congress will be an opportunity to deliberate on large and small vessel brain diseases and how they affect the mind.
We shall try to identify specific biological and psychological markers of vascular cognitive impairment, and also the genetic factors involved.